Citation Impact

Citing Papers

Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
Bariatric surgery and cardiovascular outcomes: a systematic review
2012
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants
2016 Standout
Structure of the PAPP-ABP5 complex reveals mechanism of substrate recognition
2022 StandoutNobel
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
2003
Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients.
2000
Adipose tissue heterogeneity: Implication of depot differences in adipose tissue for obesity complications
2012
Thiazolidinediones
2004 Standout
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD)
2008
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
2004
Liver fibrosis
2005 Standout
Role of AMP-activated protein kinase in mechanism of metformin action
2001 Standout
Nonalcoholic fatty liver disease
2002
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population
2004
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
Fat Accumulation in the Liver Is Associated with Defects in Insulin Suppression of Glucose Production and Serum Free Fatty Acids Independent of Obesity in Normal Men
2002
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
The metabolic syndrome
2010 Standout
The Metabolic Syndrome X
1999
Bariatric Surgery
2004 Standout
Nonalcoholic Fatty Liver Disease
2002 Standout
Maternal metabolism and obesity: modifiable determinants of pregnancy outcome
2009
Insulin resistance, iron, and the liver
2000
Non‐alcoholic fatty liver syndrome: A hepatic consequence of common metabolic diseases
2003
Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery
2002 Standout
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
2017 Standout
Benefits of lifestyle modification in NAFLD
2007
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Effect of Rosiglitazone on Insulin Sensitivity and Body Composition in Type 2 Diabetic Patients
2002
Long-Term Mortality after Gastric Bypass Surgery
2007 Standout
Maternal and child undernutrition and overweight in low-income and middle-income countries
2013 Standout
Cardiac Abnormalities as a New Manifestation of Nonalcoholic Fatty Liver Disease: Echocardiographic and Tissue Doppler Imaging Assessment
2006
Update on Nonalcoholic Fatty Liver Disease
2002
Effect of Bariatric Surgery on Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
2008
Bariatric Surgery Improves Histological Features of Nonalcoholic Fatty Liver Disease and Liver Fibrosis
2014
Bariatric Surgery and Long-term Control of Morbid Obesity
2002
Vertical Banded Gastroplasty Versus Standard or Distal Roux-en-Y Gastric Bypass Based on Specific Selection Criteria in the Morbidly Obese: Preliminary Results
1999
Obesity
2005 Standout
Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy
2012 Standout
Liver fibrosis in overweight patients
2000
Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease
2004
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
2002
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
The metabolic syndrome
2005 Standout
Current status of medical and surgical therapy for obesity
2001
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
2006 Standout
Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis
2001
Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease
2010 Standout
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
2009
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
2014 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents
2008
Global and societal implications of the diabetes epidemic
2001 StandoutNature
Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease
2005
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
2002 StandoutNobel
Pre-eclampsia
2010 Standout
Histopathology of Pediatric Nonalcoholic Fatty Liver Disease * #
2005
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Metformin reverses fatty liver disease in obese, leptin-deficient mice
2000
Childhood obesity
2010
Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association
2002
What We Talk About When We Talk About Fat
2014 Standout
Lessons from animal models of NASH
2005
Assessment and Preparation of Patients for Bariatric Surgery
2006
Association of nonalcoholic fatty liver disease with insulin resistance
1999
Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome
2008
Outdoor air pollution and asthma
2014 Standout
What Is Weight Loss After Bariatric Surgery Expressed in Percentage Total Weight Loss (%TWL)? A Systematic Review
2021
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Effect of Duodenal–Jejunal Exclusion in a Non-obese Animal Model of Type 2 Diabetes
2003
Surgery Decreases Long-term Mortality, Morbidity, and Health Care Use in Morbidly Obese Patients
2004 Standout
Mechanisms of non-alcoholic steatohepatitis
2004
Non‐alcoholic steatohepatitis: What is it, and why is it important in the Asia–Pacific region?
2003
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Interaction of obesity, metabolic syndrome and Framingham risk on steatohepatitis among healthy Taiwanese: population-based nested case-control study
2006
Bariatric Surgery and Cardiovascular Risk Factors
2011
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Restoration of Euglycemia and Normal Acute Insulin Response to Glucose in Obese Subjects With Type 2 Diabetes Following Bariatric Surgery
2003
Biliopancreatic Diversion with Duodenal Switch
1998
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
2002 StandoutNobel
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Nonalcoholic Fatty Liver Disease
2001 Standout
Diesel Exhaust Particle-Induced Airway Responses are Augmented in Obese Rats
2014
Pharmacological and surgical treatment of obesity.
2004
Effects of Bilio-Pancreatic Diversion on Diabetic Complications
2011
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
Pregnancy and fertility following bariatric surgery: a systematic review.
2008
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Fatty Liver
2007
40 YEARS OF IGF1: Role of IGF-binding proteins in regulating IGF responses to changes in metabolism
2018
Obesity Pathogenesis: An Endocrine Society Scientific Statement
2017
Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages
2013
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Mechanistic Pathways of Sex Differences in Cardiovascular Disease
2016
Meta-Analysis: Surgical Treatment of Obesity
2005 Standout
Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014
2016 Standout
Describing the Weight‐Reduced State: Physiology, Behavior, and Interventions
2021
Nonalcoholic Fatty Liver Disease
2015 Standout
Cardiovascular and Metabolic Heterogeneity of Obesity
2018
Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance
2003 StandoutScience
Obesity-Associated Liver Disease
2008
Severe Obesity in Children and Adolescents: Identification, Associated Health Risks, and Treatment Approaches
2013

Works of Simon Marceau being referenced

Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis
2003
Regional differences in adipose tissue metabolism in obese men
2007
Duodenal switch improved standard biliopancreatic diversion: a retrospective study
2008
Twenty Years of Biliopancreatic Diversion: What is the Goal of the Surgery?
2004
Upregulation of Plasma Insulin‐Like Growth Factor Binding Protein 2 Levels After Biliopancreatic Diversion in Humans
2012
Impact of bariatric surgery–induced weight loss on heart rate variability
2007
Long-Term Experience with Duodenal Switch in Adolescents
2010
Long-Term Metabolic Outcomes 5 to 20 Years After Biliopancreatic Diversion
2015
Duodenal Switch: Long-Term Results
2007
Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men
2006
MALABSORPTIVE OBESITY SURGERY
2001
Impact of bariatric surgery on cardiac structure, function and clinical manifestations in morbid obesity
2004
Long-term nutritional impact of sleeve gastrectomy
2017
Outcome of Pregnancies after Biliopancreatic Diversion
2004
Intra-abdominal Pressure in the Morbidly Obese
2005
Liver Pathology and the Metabolic Syndrome X in Severe Obesity
1999
How to Choose and Use Bariatric Surgery in 2015
2014
Asthma and Sleep Apnea in Patients with Morbid Obesity: Outcome after Bariatric Surgery
2004
Large Maternal Weight Loss From Obesity Surgery Prevents Transmission of Obesity to Children Who Were Followed for 2 to 18 Years
2006
Biliopancreatic Diversion, with Distal Gastrectomy, 250 cm and 50 cm Limbs: Long-term Results
1995
Biliopancreatic Diversion with a New Type of Gastrectomy: Some Previous Conclusions Revisited
1995
Thymic stromal lymphopoietin: an immune cytokine gene associated with the metabolic syndrome and blood pressure in severe obesity
2012
Blood pressure assessment in severe obesity: Validation of a forearm approach
2013
Rankless by CCL
2026